Therapeutic Management in Ulcerative Colitis

1. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders, Journal of Crohn’s and Colitis, Volume 11, Issue 6, 1 June 2017, Pages 649–670)10.1093/ecco-jcc/jjx008Search in Google Scholar

2. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management, Journal of Crohn’s and Colitis (2012) 6, 991–103010.1016/j.crohns.2012.09.002Search in Google Scholar

3. Christian Maaser at all, ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications, Journal of Crohn’s and Colitis, Volume 13, Issue 2, 1 February 2019, Pages 144–164K10.1093/ecco-jcc/jjy113Search in Google Scholar

4. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955;2:1041–8.10.1136/bmj.2.4947.1041Search in Google Scholar

5. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19:5A–36A10.1155/2005/269076Open DOISearch in Google Scholar

6. Orlando A. et all. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factoralpha antagonist therapy in inflammatory bowel disease.Dig LiverDis. 2011;43:1-20.10.1016/j.dld.2010.07.010Search in Google Scholar

7. Danese S. et all. Causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapy. Aliment Pharmacol Ther. 2011;34:1-1010.1111/j.1365-2036.2011.04679.xSearch in Google Scholar

8. Imdad A, Nicholson MR, Tanner-Smith EE, Zackular JP, Gomez-Duarte OG, Beaulieu DB, Acra S. Fecal transplantation for treatment of inflammatory bowel disease. Cochrane Database of Systematic Reviews 2018, Issue 11. Art. No.: CD01277410.1002/14651858.CD012774.pub2Search in Google Scholar

9. Ingrid Ordás et al, Ulcerative colitis, The Lancet, Volume 380, Issue 9853, 1606 – 16110.1016/S0140-6736(12)60150-0Search in Google Scholar

10. Sleisenger and Fordtran’s, Gastrointestinal and liver disease, Saunders, Elsevier 2010Search in Google Scholar

11. American College of Gastroenterology, Ulcerative Colitis in Adults,AmJ Gastroenterol 2010; 105:501–52310.1038/ajg.2009.72720068560Search in Google Scholar

12. Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus, Gastroenterology 2015; 148:1035–105810.1053/j.gastro.2015.03.001Search in Google Scholar

13. D’Haens G, SandbornWJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007;132:763–8610.1053/j.gastro.2006.12.03817258735Search in Google Scholar